Lenire Tinnitus Treatment Device Launches in Canada, Offering New Hope for Sufferers
Neuromod Devices has launched its Lenire tinnitus treatment device in Canada, making it available through 21 clinics across several provinces. The device, which uses bimodal neuromodulation, has been shown to provide long-term relief from tinnitus, a condition affecting a significant portion of the Canadian population. Clinical trials have demonstrated that 84% of patients experienced sustained relief for at least 12 months. The device combines mild electrical pulses to the tongue with auditory stimulation to alter brain activity and alleviate symptoms. This launch follows regulatory approval from Health Canada and marks an expansion of Lenire's availability, which has already seen success in other countries. 
